Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
60 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

IMRX — Immuneering Corporation Dilution Risk Tracker

Track IMRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IMRX — Get alerts when the score changes →

As of August 28, 2026, Immuneering Corporation (IMRX) has a DilutionWatch DilutionScore of 60/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Immuneering Corporation has a market capitalization of $373.30M, 25.94M shares outstanding, 95 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
72
💰 Cash Runway
40
📊Float Risk
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 5%
📉 Score Deterioration model 10%
• Score in HIGH risk zone (60/100)
🔔 Track IMRX — Get forecast alerts →

Market Data

Market Cap$373.30M
Shares Outstanding25.94M
FloatN/A
Cash$74.21M
Debt$3.73M
Short InterestN/A

Institutional Holdings

QoQ: ↓ 6.6% shares (2026Q1 vs prior)
95 institutional holders · 30.79M shares
#1 FMR LLC 9.70M shares
#2 Sanofi 2.71M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 2.29M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest15.40M
Days to Cover20.4
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual IMRX Dilution Snapshot

Immuneering Corporation (IMRX) has a DilutionScore of 60/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track IMRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IMRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note